Industry Research Reports

Home > Reports > New Technology > COVID-19 In-Vitro Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

COVID-19 In-Vitro Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: New Technology

Published: 2024-01-14

Pages: 133 Pages

Report ld: 2632709

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for COVID-19 In-Vitro Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for COVID-19 In-Vitro Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of COVID-19 In-Vitro Diagnostics by region & country, by Type, and by Application.

The COVID-19 In-Vitro Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COVID-19 In-Vitro Diagnostics.

Market Segmentation

Report Metric
Details
Report Title
COVID-19 In-Vitro Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global COVID-19 In-Vitro Diagnostics Companies Covered
Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Mayo Clinic Laboratories, Chembio Diagnostics, Mount Sinai Laboratory, Ortho Clinical Diagnostics, Zhejiang Orient Gene Biotech, Innovita Biological Technology, Guangzhou Wondfo Biotech, Guangdong Hecin-Scientific, Dynamiker Biotechnology (Tianjin), ADVAITE
Global COVID-19 In-Vitro Diagnostics Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global COVID-19 In-Vitro Diagnostics Market, Segment by Type
Rapid Diagnostic Test (RDT)

Enzyme Linked Immunosorbent Assay (ELISA)

Neutralization Assay
Global COVID-19 In-Vitro Diagnostics Market, Segment by Application
Home

Hospital

Clinical
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of COVID-19 In-Vitro Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of COVID-19 In-Vitro Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of COVID-19 In-Vitro Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 COVID-19 In-Vitro Diagnostics Product Introduction
    1.2 Global COVID-19 In-Vitro Diagnostics Market Size Forecast
    1.3 COVID-19 In-Vitro Diagnostics Market Trends & Drivers
        1.3.1 COVID-19 In-Vitro Diagnostics Industry Trends
        1.3.2 COVID-19 In-Vitro Diagnostics Market Drivers & Opportunity
        1.3.3 COVID-19 In-Vitro Diagnostics Market Challenges
        1.3.4 COVID-19 In-Vitro Diagnostics Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global COVID-19 In-Vitro Diagnostics Players Revenue Ranking (2023)
    2.2 Global COVID-19 In-Vitro Diagnostics Revenue by Company (2019-2024)
    2.3 Key Companies COVID-19 In-Vitro Diagnostics Manufacturing Base Distribution and Headquarters
    2.4 Key Companies COVID-19 In-Vitro Diagnostics Product Offered
    2.5 Key Companies Time to Begin Mass Production of COVID-19 In-Vitro Diagnostics
    2.6 COVID-19 In-Vitro Diagnostics Market Competitive Analysis
        2.6.1 COVID-19 In-Vitro Diagnostics Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by COVID-19 In-Vitro Diagnostics Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 In-Vitro Diagnostics as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Rapid Diagnostic Test (RDT)
        3.1.2 Enzyme Linked Immunosorbent Assay (ELISA)
        3.1.3 Neutralization Assay
    3.2 Global COVID-19 In-Vitro Diagnostics Sales Value by Type
        3.2.1 Global COVID-19 In-Vitro Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global COVID-19 In-Vitro Diagnostics Sales Value, by Type (2019-2030)
        3.2.3 Global COVID-19 In-Vitro Diagnostics Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Home
        4.1.2 Hospital
        4.1.3 Clinical
    4.2 Global COVID-19 In-Vitro Diagnostics Sales Value by Application
        4.2.1 Global COVID-19 In-Vitro Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global COVID-19 In-Vitro Diagnostics Sales Value, by Application (2019-2030)
        4.2.3 Global COVID-19 In-Vitro Diagnostics Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global COVID-19 In-Vitro Diagnostics Sales Value by Region
        5.1.1 Global COVID-19 In-Vitro Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global COVID-19 In-Vitro Diagnostics Sales Value by Region (2019-2024)
        5.1.3 Global COVID-19 In-Vitro Diagnostics Sales Value by Region (2025-2030)
        5.1.4 Global COVID-19 In-Vitro Diagnostics Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America COVID-19 In-Vitro Diagnostics Sales Value, 2019-2030
        5.2.2 North America COVID-19 In-Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe COVID-19 In-Vitro Diagnostics Sales Value, 2019-2030
        5.3.2 Europe COVID-19 In-Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific COVID-19 In-Vitro Diagnostics Sales Value, 2019-2030
        5.4.2 Asia Pacific COVID-19 In-Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America COVID-19 In-Vitro Diagnostics Sales Value, 2019-2030
        5.5.2 South America COVID-19 In-Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa COVID-19 In-Vitro Diagnostics Sales Value, 2019-2030
        5.6.2 Middle East & Africa COVID-19 In-Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions COVID-19 In-Vitro Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions COVID-19 In-Vitro Diagnostics Sales Value
    6.3 United States
        6.3.1 United States COVID-19 In-Vitro Diagnostics Sales Value, 2019-2030
        6.3.2 United States COVID-19 In-Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States COVID-19 In-Vitro Diagnostics Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe COVID-19 In-Vitro Diagnostics Sales Value, 2019-2030
        6.4.2 Europe COVID-19 In-Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe COVID-19 In-Vitro Diagnostics Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China COVID-19 In-Vitro Diagnostics Sales Value, 2019-2030
        6.5.2 China COVID-19 In-Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.5.3 China COVID-19 In-Vitro Diagnostics Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan COVID-19 In-Vitro Diagnostics Sales Value, 2019-2030
        6.6.2 Japan COVID-19 In-Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan COVID-19 In-Vitro Diagnostics Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea COVID-19 In-Vitro Diagnostics Sales Value, 2019-2030
        6.7.2 South Korea COVID-19 In-Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea COVID-19 In-Vitro Diagnostics Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia COVID-19 In-Vitro Diagnostics Sales Value, 2019-2030
        6.8.2 Southeast Asia COVID-19 In-Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia COVID-19 In-Vitro Diagnostics Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India COVID-19 In-Vitro Diagnostics Sales Value, 2019-2030
        6.9.2 India COVID-19 In-Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.9.3 India COVID-19 In-Vitro Diagnostics Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Cellex
        7.1.1 Cellex Profile
        7.1.2 Cellex Main Business
        7.1.3 Cellex COVID-19 In-Vitro Diagnostics Products, Services and Solutions
        7.1.4 Cellex COVID-19 In-Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
        7.1.5 Cellex Recent Developments
    7.2 Abbott
        7.2.1 Abbott Profile
        7.2.2 Abbott Main Business
        7.2.3 Abbott COVID-19 In-Vitro Diagnostics Products, Services and Solutions
        7.2.4 Abbott COVID-19 In-Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
        7.2.5 Abbott Recent Developments
    7.3 Roche
        7.3.1 Roche Profile
        7.3.2 Roche Main Business
        7.3.3 Roche COVID-19 In-Vitro Diagnostics Products, Services and Solutions
        7.3.4 Roche COVID-19 In-Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
        7.3.5 BioMedomics Recent Developments
    7.4 BioMedomics
        7.4.1 BioMedomics Profile
        7.4.2 BioMedomics Main Business
        7.4.3 BioMedomics COVID-19 In-Vitro Diagnostics Products, Services and Solutions
        7.4.4 BioMedomics COVID-19 In-Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
        7.4.5 BioMedomics Recent Developments
    7.5 BD
        7.5.1 BD Profile
        7.5.2 BD Main Business
        7.5.3 BD COVID-19 In-Vitro Diagnostics Products, Services and Solutions
        7.5.4 BD COVID-19 In-Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
        7.5.5 BD Recent Developments
    7.6 Henry Schein
        7.6.1 Henry Schein Profile
        7.6.2 Henry Schein Main Business
        7.6.3 Henry Schein COVID-19 In-Vitro Diagnostics Products, Services and Solutions
        7.6.4 Henry Schein COVID-19 In-Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
        7.6.5 Henry Schein Recent Developments
    7.7 Safecare Bio-Tech
        7.7.1 Safecare Bio-Tech Profile
        7.7.2 Safecare Bio-Tech Main Business
        7.7.3 Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Products, Services and Solutions
        7.7.4 Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
        7.7.5 Safecare Bio-Tech Recent Developments
    7.8 Mayo Clinic Laboratories
        7.8.1 Mayo Clinic Laboratories Profile
        7.8.2 Mayo Clinic Laboratories Main Business
        7.8.3 Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Products, Services and Solutions
        7.8.4 Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
        7.8.5 Mayo Clinic Laboratories Recent Developments
    7.9 Chembio Diagnostics
        7.9.1 Chembio Diagnostics Profile
        7.9.2 Chembio Diagnostics Main Business
        7.9.3 Chembio Diagnostics COVID-19 In-Vitro Diagnostics Products, Services and Solutions
        7.9.4 Chembio Diagnostics COVID-19 In-Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
        7.9.5 Chembio Diagnostics Recent Developments
    7.10 Mount Sinai Laboratory
        7.10.1 Mount Sinai Laboratory Profile
        7.10.2 Mount Sinai Laboratory Main Business
        7.10.3 Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Products, Services and Solutions
        7.10.4 Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
        7.10.5 Mount Sinai Laboratory Recent Developments
    7.11 Ortho Clinical Diagnostics
        7.11.1 Ortho Clinical Diagnostics Profile
        7.11.2 Ortho Clinical Diagnostics Main Business
        7.11.3 Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Products, Services and Solutions
        7.11.4 Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
        7.11.5 Ortho Clinical Diagnostics Recent Developments
    7.12 Zhejiang Orient Gene Biotech
        7.12.1 Zhejiang Orient Gene Biotech Profile
        7.12.2 Zhejiang Orient Gene Biotech Main Business
        7.12.3 Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Products, Services and Solutions
        7.12.4 Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
        7.12.5 Zhejiang Orient Gene Biotech Recent Developments
    7.13 Innovita Biological Technology
        7.13.1 Innovita Biological Technology Profile
        7.13.2 Innovita Biological Technology Main Business
        7.13.3 Innovita Biological Technology COVID-19 In-Vitro Diagnostics Products, Services and Solutions
        7.13.4 Innovita Biological Technology COVID-19 In-Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
        7.13.5 Innovita Biological Technology Recent Developments
    7.14 Guangzhou Wondfo Biotech
        7.14.1 Guangzhou Wondfo Biotech Profile
        7.14.2 Guangzhou Wondfo Biotech Main Business
        7.14.3 Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Products, Services and Solutions
        7.14.4 Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
        7.14.5 Guangzhou Wondfo Biotech Recent Developments
    7.15 Guangdong Hecin-Scientific
        7.15.1 Guangdong Hecin-Scientific Profile
        7.15.2 Guangdong Hecin-Scientific Main Business
        7.15.3 Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Products, Services and Solutions
        7.15.4 Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
        7.15.5 Guangdong Hecin-Scientific Recent Developments
    7.16 Dynamiker Biotechnology (Tianjin)
        7.16.1 Dynamiker Biotechnology (Tianjin) Profile
        7.16.2 Dynamiker Biotechnology (Tianjin) Main Business
        7.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Products, Services and Solutions
        7.16.4 Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
        7.16.5 Dynamiker Biotechnology (Tianjin) Recent Developments
    7.17 ADVAITE
        7.17.1 ADVAITE Profile
        7.17.2 ADVAITE Main Business
        7.17.3 ADVAITE COVID-19 In-Vitro Diagnostics Products, Services and Solutions
        7.17.4 ADVAITE COVID-19 In-Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
        7.17.5 ADVAITE Recent Developments

 8 Industry Chain Analysis
    8.1 COVID-19 In-Vitro Diagnostics Industrial Chain
    8.2 COVID-19 In-Vitro Diagnostics Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 COVID-19 In-Vitro Diagnostics Sales Model
        8.5.2 Sales Channel
        8.5.3 COVID-19 In-Vitro Diagnostics Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. COVID-19 In-Vitro Diagnostics Market Trends
    Table 2. COVID-19 In-Vitro Diagnostics Market Drivers & Opportunity
    Table 3. COVID-19 In-Vitro Diagnostics Market Challenges
    Table 4. COVID-19 In-Vitro Diagnostics Market Restraints
    Table 5. Global COVID-19 In-Vitro Diagnostics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies COVID-19 In-Vitro Diagnostics Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies COVID-19 In-Vitro Diagnostics Product Type
    Table 9. Key Companies Time to Begin Mass Production of COVID-19 In-Vitro Diagnostics
    Table 10. Global COVID-19 In-Vitro Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 In-Vitro Diagnostics as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global COVID-19 In-Vitro Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global COVID-19 In-Vitro Diagnostics Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global COVID-19 In-Vitro Diagnostics Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global COVID-19 In-Vitro Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global COVID-19 In-Vitro Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global COVID-19 In-Vitro Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global COVID-19 In-Vitro Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global COVID-19 In-Vitro Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global COVID-19 In-Vitro Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global COVID-19 In-Vitro Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global COVID-19 In-Vitro Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global COVID-19 In-Vitro Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global COVID-19 In-Vitro Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global COVID-19 In-Vitro Diagnostics Sales Value by Region (2019-2024) & (%)
    Table 27. Global COVID-19 In-Vitro Diagnostics Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions COVID-19 In-Vitro Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions COVID-19 In-Vitro Diagnostics Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions COVID-19 In-Vitro Diagnostics Sales Value, (2025-2030) & (US$ Million)
    Table 31. Cellex Basic Information List
    Table 32. Cellex Description and Business Overview
    Table 33. Cellex COVID-19 In-Vitro Diagnostics Products, Services and Solutions
    Table 34. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Cellex (2019-2024)
    Table 35. Cellex Recent Developments
    Table 36. Abbott Basic Information List
    Table 37. Abbott Description and Business Overview
    Table 38. Abbott COVID-19 In-Vitro Diagnostics Products, Services and Solutions
    Table 39. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Abbott (2019-2024)
    Table 40. Abbott Recent Developments
    Table 41. Roche Basic Information List
    Table 42. Roche Description and Business Overview
    Table 43. Roche COVID-19 In-Vitro Diagnostics Products, Services and Solutions
    Table 44. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Roche (2019-2024)
    Table 45. Roche Recent Developments
    Table 46. BioMedomics Basic Information List
    Table 47. BioMedomics Description and Business Overview
    Table 48. BioMedomics COVID-19 In-Vitro Diagnostics Products, Services and Solutions
    Table 49. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of BioMedomics (2019-2024)
    Table 50. BioMedomics Recent Developments
    Table 51. BD Basic Information List
    Table 52. BD Description and Business Overview
    Table 53. BD COVID-19 In-Vitro Diagnostics Products, Services and Solutions
    Table 54. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of BD (2019-2024)
    Table 55. BD Recent Developments
    Table 56. Henry Schein Basic Information List
    Table 57. Henry Schein Description and Business Overview
    Table 58. Henry Schein COVID-19 In-Vitro Diagnostics Products, Services and Solutions
    Table 59. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Henry Schein (2019-2024)
    Table 60. Henry Schein Recent Developments
    Table 61. Safecare Bio-Tech Basic Information List
    Table 62. Safecare Bio-Tech Description and Business Overview
    Table 63. Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Products, Services and Solutions
    Table 64. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Safecare Bio-Tech (2019-2024)
    Table 65. Safecare Bio-Tech Recent Developments
    Table 66. Mayo Clinic Laboratories Basic Information List
    Table 67. Mayo Clinic Laboratories Description and Business Overview
    Table 68. Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Products, Services and Solutions
    Table 69. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Mayo Clinic Laboratories (2019-2024)
    Table 70. Mayo Clinic Laboratories Recent Developments
    Table 71. Chembio Diagnostics Basic Information List
    Table 72. Chembio Diagnostics Description and Business Overview
    Table 73. Chembio Diagnostics COVID-19 In-Vitro Diagnostics Products, Services and Solutions
    Table 74. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Chembio Diagnostics (2019-2024)
    Table 75. Chembio Diagnostics Recent Developments
    Table 76. Mount Sinai Laboratory Basic Information List
    Table 77. Mount Sinai Laboratory Description and Business Overview
    Table 78. Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Products, Services and Solutions
    Table 79. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Mount Sinai Laboratory (2019-2024)
    Table 80. Mount Sinai Laboratory Recent Developments
    Table 81. Ortho Clinical Diagnostics Basic Information List
    Table 82. Ortho Clinical Diagnostics Description and Business Overview
    Table 83. Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Products, Services and Solutions
    Table 84. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Ortho Clinical Diagnostics (2019-2024)
    Table 85. Ortho Clinical Diagnostics Recent Developments
    Table 86. Zhejiang Orient Gene Biotech Basic Information List
    Table 87. Zhejiang Orient Gene Biotech Description and Business Overview
    Table 88. Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Products, Services and Solutions
    Table 89. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Zhejiang Orient Gene Biotech (2019-2024)
    Table 90. Zhejiang Orient Gene Biotech Recent Developments
    Table 91. Innovita Biological Technology Basic Information List
    Table 92. Innovita Biological Technology Description and Business Overview
    Table 93. Innovita Biological Technology COVID-19 In-Vitro Diagnostics Products, Services and Solutions
    Table 94. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Innovita Biological Technology (2019-2024)
    Table 95. Innovita Biological Technology Recent Developments
    Table 96. Guangzhou Wondfo Biotech Basic Information List
    Table 97. Guangzhou Wondfo Biotech Description and Business Overview
    Table 98. Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Products, Services and Solutions
    Table 99. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Guangzhou Wondfo Biotech (2019-2024)
    Table 100. Guangzhou Wondfo Biotech Recent Developments
    Table 101. Guangdong Hecin-Scientific Basic Information List
    Table 102. Guangdong Hecin-Scientific Description and Business Overview
    Table 103. Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Products, Services and Solutions
    Table 104. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Guangdong Hecin-Scientific (2019-2024)
    Table 105. Guangdong Hecin-Scientific Recent Developments
    Table 106. Dynamiker Biotechnology (Tianjin) Basic Information List
    Table 107. Dynamiker Biotechnology (Tianjin) Description and Business Overview
    Table 108. Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Products, Services and Solutions
    Table 109. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Dynamiker Biotechnology (Tianjin) (2019-2024)
    Table 110. Dynamiker Biotechnology (Tianjin) Recent Developments
    Table 111. ADVAITE Basic Information List
    Table 112. ADVAITE Description and Business Overview
    Table 113. ADVAITE COVID-19 In-Vitro Diagnostics Products, Services and Solutions
    Table 114. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of ADVAITE (2019-2024)
    Table 115. ADVAITE Recent Developments
    Table 116. Key Raw Materials Lists
    Table 117. Raw Materials Key Suppliers Lists
    Table 118. COVID-19 In-Vitro Diagnostics Downstream Customers
    Table 119. COVID-19 In-Vitro Diagnostics Distributors List
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
    Table 123. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. COVID-19 In-Vitro Diagnostics Product Picture
    Figure 2. Global COVID-19 In-Vitro Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global COVID-19 In-Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 4. COVID-19 In-Vitro Diagnostics Report Years Considered
    Figure 5. Global COVID-19 In-Vitro Diagnostics Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by COVID-19 In-Vitro Diagnostics Revenue in 2023
    Figure 7. COVID-19 In-Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Rapid Diagnostic Test (RDT) Picture
    Figure 9. Enzyme Linked Immunosorbent Assay (ELISA) Picture
    Figure 10. Neutralization Assay Picture
    Figure 11. Global COVID-19 In-Vitro Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global COVID-19 In-Vitro Diagnostics Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Home
    Figure 14. Product Picture of Hospital
    Figure 15. Product Picture of Clinical
    Figure 16. Global COVID-19 In-Vitro Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global COVID-19 In-Vitro Diagnostics Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America COVID-19 In-Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America COVID-19 In-Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe COVID-19 In-Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe COVID-19 In-Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific COVID-19 In-Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific COVID-19 In-Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America COVID-19 In-Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America COVID-19 In-Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa COVID-19 In-Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa COVID-19 In-Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions COVID-19 In-Vitro Diagnostics Sales Value (%), (2019-2030)
    Figure 29. United States COVID-19 In-Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States COVID-19 In-Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States COVID-19 In-Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe COVID-19 In-Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe COVID-19 In-Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe COVID-19 In-Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 35. China COVID-19 In-Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China COVID-19 In-Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 37. China COVID-19 In-Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan COVID-19 In-Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan COVID-19 In-Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan COVID-19 In-Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea COVID-19 In-Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea COVID-19 In-Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea COVID-19 In-Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia COVID-19 In-Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia COVID-19 In-Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia COVID-19 In-Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 47. India COVID-19 In-Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India COVID-19 In-Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 49. India COVID-19 In-Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 50. COVID-19 In-Vitro Diagnostics Industrial Chain
    Figure 51. COVID-19 In-Vitro Diagnostics Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation

Description

The global market for COVID-19 In-Vitro Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for COVID-19 In-Vitro Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of COVID-19 In-Vitro Diagnostics by region & country, by Type, and by Application.

The COVID-19 In-Vitro Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COVID-19 In-Vitro Diagnostics.

Market Segmentation